What ethical considerations are associated with the commercialization of cannabinoid products?
What ethical considerations are associated with the commercialization of cannabinoid products? The commercialization of cannabinoid products raises several ethical considerations, including issues of safety, quality control, and equitable access. There is a need to ensure that cannabinoid products are accurately labeled and free from contaminants, as poor quality can harm consumers. Additionally, the marketing of cannabinoid products must be ethical and not exploit vulnerable populations seeking relief for medical conditions. Ensuring equitable access to cannabinoid therapies is also essential, as commercialization can lead to disparities in access for marginalized groups. Ethical oversight and regulatory frameworks are necessary to protect consumers and promote responsible practices in the cannabinoid industry (Schmidt et al., 2021).